Coronary Arterial Microcirculation and Metabolism
Launched by SHAANXI PROVINCIAL PEOPLE'S HOSPITAL · Jul 10, 2025
Trial Information
Current as of August 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with normal coronary angiography or stenosis less than 50%
- Exclusion Criteria:
- • Coronary angiography indicates patients with coronary stenosis greater than 50%.
About Shaanxi Provincial People's Hospital
Shaanxi Provincial People's Hospital is a leading medical institution dedicated to advancing healthcare through innovative clinical research and trials. Located in Xi'an, China, the hospital is affiliated with the Shaanxi University of Traditional Chinese Medicine and is recognized for its commitment to high-quality patient care, education, and research. With a multidisciplinary approach, the hospital collaborates with various healthcare professionals to conduct rigorous clinical trials aimed at improving treatment outcomes and enhancing medical knowledge across a range of therapeutic areas. Its state-of-the-art facilities and experienced research team ensure the successful execution of trials, contributing significantly to the advancement of medical science and patient care in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported